HealthEquity (NASDAQ:HQY) Price Target Lowered to $94.00 at The Goldman Sachs Group

HealthEquity (NASDAQ:HQY) had its target price lowered by investment analysts at The Goldman Sachs Group from $107.00 to $94.00 in a research note issued to investors on Thursday,Benzinga reports. The brokerage presently has a “neutral” rating on the stock. The Goldman Sachs Group’s target price indicates a potential upside of 8.10% from the company’s current price.

A number of other research firms also recently issued reports on HQY. Raymond James upgraded shares of HealthEquity from an “outperform” rating to a “strong-buy” rating and decreased their price objective for the stock from $120.00 to $115.00 in a report on Tuesday. Mizuho initiated coverage on shares of HealthEquity in a research note on Wednesday, December 4th. They set an “outperform” rating and a $126.00 price target for the company. Royal Bank of Canada upped their price objective on HealthEquity from $100.00 to $105.00 and gave the company an “outperform” rating in a research note on Tuesday, December 10th. Wells Fargo & Company increased their price objective on HealthEquity from $110.00 to $125.00 and gave the company an “overweight” rating in a report on Wednesday, February 26th. Finally, JMP Securities boosted their target price on HealthEquity from $105.00 to $107.00 and gave the company a “market outperform” rating in a research note on Tuesday, December 10th. One investment analyst has rated the stock with a hold rating, eleven have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat, HealthEquity has an average rating of “Buy” and an average target price of $112.23.

HealthEquity Trading Down 2.1 %

Shares of HealthEquity stock opened at $86.96 on Thursday. The firm has a market cap of $7.52 billion, a PE ratio of 79.78, a P/E/G ratio of 1.60 and a beta of 0.62. HealthEquity has a 1 year low of $65.01 and a 1 year high of $115.59. The company has a debt-to-equity ratio of 0.51, a current ratio of 3.20 and a quick ratio of 3.20. The stock has a fifty day moving average price of $103.63 and a 200-day moving average price of $95.91.

Insider Buying and Selling

In related news, Director Robert W. Selander sold 5,750 shares of the business’s stock in a transaction that occurred on Monday, February 10th. The shares were sold at an average price of $111.29, for a total transaction of $639,917.50. Following the completion of the transaction, the director now owns 78,219 shares of the company’s stock, valued at approximately $8,704,992.51. The trade was a 6.85 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. 2.20% of the stock is currently owned by insiders.

Institutional Trading of HealthEquity

Several institutional investors and hedge funds have recently bought and sold shares of HQY. Wealth Enhancement Advisory Services LLC increased its holdings in shares of HealthEquity by 40.2% in the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 5,115 shares of the company’s stock worth $491,000 after purchasing an additional 1,466 shares during the period. ABLE Financial Group LLC grew its position in HealthEquity by 8.5% during the fourth quarter. ABLE Financial Group LLC now owns 21,725 shares of the company’s stock worth $2,085,000 after buying an additional 1,709 shares in the last quarter. Forum Financial Management LP purchased a new position in HealthEquity during the fourth quarter worth about $214,000. Public Employees Retirement System of Ohio increased its stake in HealthEquity by 6.1% in the 4th quarter. Public Employees Retirement System of Ohio now owns 97,323 shares of the company’s stock worth $9,338,000 after acquiring an additional 5,569 shares during the last quarter. Finally, GTS Securities LLC purchased a new stake in shares of HealthEquity in the 4th quarter valued at about $239,000. 99.55% of the stock is currently owned by hedge funds and other institutional investors.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.